RecruitingPhase 4NCT07221617

Oral Methadone in Cardiac Surgery

Oral Methadone In Cardiac Surgery


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Jan 13, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the effects of administration of oral methadone preoperatively and intravenous methadone upon induction of general anesthesia on postoperative pain for patients undergoing elective cardiac surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Undergoing elective cardiac surgery

Exclusion Criteria9

  • Chronic pain requiring opioid medications as an outpatient
  • Opioid use disorder on medication assistance treatment
  • Prolonged QTc >500ms
  • Chronic kidney disease with eGFR < 30mL/min
  • Documented cirrhosis
  • Intolerance to methadone
  • Admitted inpatient in an intensive care unit (ICU) immediately prior to surgery
  • Pregnancy at the time of surgery
  • Subsequent surgeries after index surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethadone, oral

Patients will receive 0.4mg/kg PO methadone immediately prior to transport to the operating room

DRUGMethadone, intravenously

Patients will receive 0.3mg/kg methadone intravenously after induction of general anesthesia


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07221617


Related Trials